Strides Arcolab gains as government clears Mylan's deal

Prime minister Manmohan Singh on Friday cleared the FDI of Strides Arcolab-Mylan Rs 9,920 crore ($1.6 billion) deal.

is trading higher by 2% at Rs 813 on reports that Prime minister Manmohan Singh on Friday cleared the foreign direct investment (FDI) of Strides Arcolab-Rs 9,920 crore ($1.6 billion) deal.

On February 28 this year, US-based and Bangalore-based signed the agreement under which the US drug major was to acquire Agila Specialties, the injectible medicine business of Strides.

Now, the deal will be brought to the Cabinet Committee on Economic Affairs (CCEA) under existing policy to get the final approval.

The stock opened at Rs 803 and touched high of Rs 835 on BSE. A combined 179,299 shares change hands on the counter till 1035 house on BSE and NSE.
 

image
Business Standard
177 22
Business Standard

Strides Arcolab gains as government clears Mylan's deal

Prime minister Manmohan Singh on Friday cleared the FDI of Strides Arcolab-Mylan Rs 9,920 crore ($1.6 billion) deal.

SI Reporter  |  Mumbai 

is trading higher by 2% at Rs 813 on reports that Prime minister Manmohan Singh on Friday cleared the foreign direct investment (FDI) of Strides Arcolab-Rs 9,920 crore ($1.6 billion) deal.

On February 28 this year, US-based and Bangalore-based signed the agreement under which the US drug major was to acquire Agila Specialties, the injectible medicine business of Strides.


Now, the deal will be brought to the Cabinet Committee on Economic Affairs (CCEA) under existing policy to get the final approval.

The stock opened at Rs 803 and touched high of Rs 835 on BSE. A combined 179,299 shares change hands on the counter till 1035 house on BSE and NSE.
 

RECOMMENDED FOR YOU

Strides Arcolab gains as government clears Mylan's deal

Prime minister Manmohan Singh on Friday cleared the FDI of Strides Arcolab-Mylan Rs 9,920 crore ($1.6 billion) deal.

Prime minister Manmohan Singh on Friday cleared the FDI of Strides Arcolab-Mylan Rs 9,920 crore ($1.6 billion) deal.
is trading higher by 2% at Rs 813 on reports that Prime minister Manmohan Singh on Friday cleared the foreign direct investment (FDI) of Strides Arcolab-Rs 9,920 crore ($1.6 billion) deal.

On February 28 this year, US-based and Bangalore-based signed the agreement under which the US drug major was to acquire Agila Specialties, the injectible medicine business of Strides.

Now, the deal will be brought to the Cabinet Committee on Economic Affairs (CCEA) under existing policy to get the final approval.

The stock opened at Rs 803 and touched high of Rs 835 on BSE. A combined 179,299 shares change hands on the counter till 1035 house on BSE and NSE.
 
image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard